|Bid||105.10 x 3000|
|Ask||105.40 x 800|
|Day's range||103.02 - 105.40|
|52-week range||28.00 - 131.00|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||10 Nov 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||118.47|
Johnson and Johnson expects vaccine data next week.
The Zacks Analyst Blog Highlights: Moderna, Pfizer, BioNTech and AstraZeneca
Moderna's (MRNA) progress with coronavirus vaccine development and its approval is driving its share prices for the past year. Will the trend continue?